1. Home
  2. MOS vs RGEN Comparison

MOS vs RGEN Comparison

Compare MOS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mosaic Company (The)

MOS

Mosaic Company (The)

HOLD

Current Price

$24.50

Market Cap

8.3B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$169.92

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOS
RGEN
Founded
1987
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MOS
RGEN
Price
$24.50
$169.92
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$34.93
$170.90
AVG Volume (30 Days)
8.0M
815.2K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
3.59%
N/A
EPS Growth
235.95
N/A
EPS
3.87
0.03
Revenue
$11,894,600,000.00
$707,890,000.00
Revenue This Year
$16.57
$17.50
Revenue Next Year
$1.03
$12.74
P/E Ratio
$6.34
$5,539.04
Revenue Growth
3.83
11.74
52 Week Low
$22.36
$102.97
52 Week High
$38.23
$182.52

Technical Indicators

Market Signals
Indicator
MOS
RGEN
Relative Strength Index (RSI) 34.69 65.65
Support Level $23.35 $146.56
Resistance Level $24.42 $173.65
Average True Range (ATR) 0.70 6.93
MACD 0.14 1.83
Stochastic Oscillator 38.89 85.65

Price Performance

Historical Comparison
MOS
RGEN

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida and Peru and potash mines in Saskatchewan and New Mexico. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: